
Results
20
Companies which are more than 50% undervalued based on analyst price target.
20 companies
ABL Bio
Market Cap: ₩4.9t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩86,800.00
7D
4.2%
1Y
-0.7%
LigaChem Biosciences
Market Cap: ₩4.2t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩114,400.00
7D
3.2%
1Y
-26.8%
Voronoi
Market Cap: ₩3.3t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩180,700.00
7D
14.7%
1Y
47.3%
ST PharmLtd
Market Cap: ₩2.2t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩107,600.00
7D
6.2%
1Y
15.9%
L&C BIOLTD
Market Cap: ₩1.5t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩54,700.00
7D
-14.3%
1Y
74.2%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,300.00
7D
8.3%
1Y
11.0%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩123,300.00
7D
-3.7%
1Y
-8.0%
HK inno.N
Market Cap: ₩1.2t
Engages in the pharmaceutical business in South Korea.
A195940
₩41,150.00
7D
-0.2%
1Y
-8.6%
DongKook Pharmaceutical
Market Cap: ₩922.5b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩20,450.00
7D
6.5%
1Y
15.4%
Chong Kun Dang Pharmaceutical
Market Cap: ₩898.6b
Manufactures, markets, and sells medicines in South Korea and internationally.
A185750
₩68,200.00
7D
-0.9%
1Y
-17.8%
AprilBioLtd
Market Cap: ₩801.9b
Develops long-acting type biobetter and antibody biologics.
A397030
₩29,150.00
7D
2.6%
1Y
35.3%
Boryung
Market Cap: ₩775.5b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩9,180.00
7D
4.4%
1Y
7.4%
Pharmicell
Market Cap: ₩715.2b
A biopharmaceutical company, develops and sells autologous drugs in South Korea and internationally.
A005690
₩11,920.00
7D
5.7%
1Y
2.1%
Dong-A Socio Holdings
Market Cap: ₩625.8b
Engages in the pharmaceutical business in South Korea.
A000640
₩94,400.00
7D
6.7%
1Y
-11.8%
Dong-A ST
Market Cap: ₩368.2b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩38,200.00
7D
0.9%
1Y
-12.9%
Humedix
Market Cap: ₩279.7b
Engages in the manufacture and sale of various pharmaceutical products in South Korea.
A200670
₩27,100.00
7D
-1.3%
1Y
-54.2%
BINEX
Market Cap: ₩232.5b
Operates as a pharmaceutical company in South Korea.
A053030
₩7,300.00
7D
6.1%
1Y
-55.9%
Whan In PharmLtd
Market Cap: ₩188.0b
Manufactures and sells various pharmaceutical products in South Korea.
A016580
₩10,170.00
7D
-1.4%
1Y
-11.8%
Daewon Pharmaceutical
Market Cap: ₩171.0b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩7,980.00
7D
2.4%
1Y
-40.0%
Macrogen
Market Cap: ₩136.4b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩12,580.00
7D
3.5%
1Y
-21.0%